Search clinical trials for: pneumococcal vaccine

Total 10095 results

Boston Medical Center
Merck Sharp & Dohme LLC

Completed

Streptococcus Pneumonia: Effects of PCV13 on Pneumococcal Carriage

Nasopharyngeal Carriage of S. Pneumoniae

United States
Merck Sharp & Dohme LLC

Completed

Safety, Tolerability and Immunogenicity of Pneumovax 23 in Healthy Adults in India (V110-011)

Pneumococcal Infection
Agence de Médecine Préventive, France

Completed

Immunogenicity and Reactogenicity of PCV13 Among Infants and Children in Burkina Faso (PCV13-Bobo)

Pneumococcal Infections

Burkina Faso
CHU de Quebec-Universite Laval
GlaxoSmithKline

Unknown

Impact of Introduction of PHiD-CV for Nunavik Children, Quebec, Canada (Nunavik2)

Acute Upper Respiratory Infection | Acute Lower Respiratory Tract Infection | Invasive Pneumococcal Disease, Protection Against | Otitis Media (OM)

Canada
Hospital General de Niños Pedro de Elizalde

Completed

Bacterial Pneumonia Score (BPS) Guided Antibiotic Use in Children With Pneumonia and Pneumococcal Vaccine

Community Acquired Pneumonia

Argentina
ALK-Abelló A/S

Completed

Efficacy and Safety of Grass Sublingual Tablet in Adults (P05238 AM3)(COMPLETED)

Allergy | Rhinitis | Conjunctivitis | Rhinoconjunctivitis
Pfizer

Completed

Prevenar13 Post Market Surveillance

Healthy

Korea, Republic of
H. Lee Moffitt Cancer Center and Research Institute

Completed

Exploration of Immune Response to Early PCV13 Vaccination in Conjunction With Autologous Transplant (PCV13)

Multiple Myeloma

United States
Aghia Sophia Children's Hospital of Athens

Unknown

Immunological Memory Induced by the 13valent Pneumococcal Conjugate(PCV13) and 23valent Plain Polysaccharide Vaccine(PPV23) in HIV-infected Patients

HIV Infection
Beaumont Hospital

Completed

Seasonal Trends in Pneumococcal Carriage in COPD Patients (Helios)

Chronic Obstructive Pulmonary Disease (COPD)

Ireland
Pfizer

Completed

Safety Surveillance of Pneumococcal 13-valent Conjugate Vaccine Among Filipinos

Pneumococcal Disease

Philippines
Novartis
Novartis Vaccines

Completed

Second Extension Study to Evaluate Safety and Tolerability of Influenza Vaccines in Adults and Elderly, and to Evaluate Immunogenicity and Concomitant Vaccination With Pneumococcal Vaccine in a Subgroup

Influenza

Poland
GlaxoSmithKline

Completed

Post Marketing Surveillance of Synflorix Vaccine Safety Among Infants in Korea

Infections, Streptococcal

Korea, Republic of
GlaxoSmithKline

Completed

A Study in Children With Different Formulations of GSK Biologicals' 11 Valent Pneumococcal Conjugate Vaccine

Streptococcal Infections

Germany
University of Siena
Catholic University of the Sacred Heart

Withdrawn

Antibodies and Memory Cells Role After Different Pneumococcal Vaccines in HIV Adults

Pneumococcal Infections | HIV

Italy
Eli Lilly and Company

Completed

A Study of the Immune Response to Vaccines and Ixekizumab (LY2439821) in Healthy Participants

Healthy

United States
National Institute of Allergy and Infectious Diseases...

Completed

Pneumococcal Reference Standard

Pneumococcal Infections

United States
Michigan State University
Pfizer

Completed

Study Response of 13-valent Conjugate Pneumococcal Vaccine in Patients With End Stage Renal Disease

End Stage Renal Disease

United States
GlaxoSmithKline

Completed

Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' 10-valent Pneumococcal Conjugate Vaccine.

Infections, Streptococcal

Spain, Germany, Poland
GlaxoSmithKline

Completed

Safety and Immunogenicity Study of a Booster Dose of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine

Infections, Streptococcal

Finland
GlaxoSmithKline

Completed

Immune Memory Evaluation in Children Following a Primary Vaccination With Pneumococcal Conjugate Vaccines.

Infections, Streptococcal

Germany
GlaxoSmithKline

Completed

Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' 10-valent Pneumococcal Conjugate Vaccine.

Hepatitis A

Chile
GlaxoSmithKline

Completed

A Lot-to-lot Consistency (3 Lots of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine) & Non-inferiority Study

Infections, Streptococcal

Finland, France, Poland
GlaxoSmithKline

Completed

Multicentre Booster & Immune Memory Study of a Booster Dose of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine or a Single Dose of 23-valent Plain Polysaccharide Vaccine in Healthy Children Aged 11-18 Mths, Previously Vaccinated in Study 103488

Hepatitis B | Tetanus | Diphtheria | Acellular Pertussis | Poliomyelitis | Haemophilus Influenzae Type b

Germany
GlaxoSmithKline

Completed

Study of Two Doses of GSK Biologicals' Live Attenuated HRV Vaccine (Two Different Formulations) in Healthy Infants.

Infections, Rotavirus
Seoul National University Hospital

Completed

Exploration of microRNA and Metabolomics Biomarkers Predicting Drug Induced Liver Injury in Elderly People

Healthy

Korea, Republic of
Assistance Publique - Hôpitaux de Paris

Completed

Residual Anti-pneumococcal Immunity After Pneumococcal Immunization in ANCA-associated Vasculitis

ANCA-associated Vasculitis | Pneumococcal Infection

France
Pfizer

Completed

Study Evaluating Serum Collected From Healthy Adults For Development of Pneumococcal Opsonophagocytic Assay

Healthy

United States
Assistance Publique - Hôpitaux de Paris

Completed

Safety Study of Two Vaccine Strategies in Patients With Systemic Lupus Erythematosus (VACCILUP)

Lupus Erythematosus, Systemic

France
Pfizer

Completed

13-valent Pneumococcal Conjugate Vaccine Study in Adults and Children in India

Prevention of Pneumonia and Invasive Disease Caused by the Serotypes in 13vPnC

India
Pfizer

Completed

Concomitant Administration of 13-valent Pneumococcal Conjugate Vaccine (13vPnC) With Influenza Vaccine in 23-valent Pneumococcal Polysaccharide (23vPS) Pre-vaccinated Adults.

PREVENTION OF INVASIVE PNEUMOCOCCAL DISEASE

United States
National Cancer Institute (NCI)

Terminated

Improving the Immune System With Human IL-7 Vaccine in Older Subjects Who Have Had Chemotherapy

Breast Cancer | Bladder Cancer | Colon Cancer

United States
Uppsala University

Completed

Pneumococci and Hib Vaccination After Neurotrauma or Neurosurgery

Meningitis
Beijing Chaoyang District Centre for Disease Control...

Unknown

Safety Study of Pneumococcal 13-valent Conjugate Vaccine in Healthy People Aged 2 Months and Older

Pneumococcal 13-valent Conjugate Vaccine
Sanofi Pasteur, a Sanofi Company

Completed

Study to Compare Pediacel® to Infanrix®-IPV+Hib When Both Are Co-Administered With Prevenar® in Infants and Toddlers

Pertussis | Tetanus | Diphtheria | Poliomyelitis | Haemophilus Influenzae Type b

France, Poland
Centers for Disease Control and Prevention, China
Beijing Center for Disease Control and Prevention; Beijing Municipal Health...

Completed

PCV7 in the Prevention of Nasopharyngeal Carriage of Vaccine Serotype (VT) Streptococcus Pneumoniae

Nasopharyngeal Diseases | Streptococcal Pneumonia | Vaccination Adverse Event

China
Sanofi Pasteur, a Sanofi Company

Completed

Study of the Safety of Menactra® Vaccine When Administered With Other Pediatric Vaccines to Healthy Toddlers

Measles | Rubella | Mumps | Varicella | Meningococcal Meningitis

United States, Chile
GlaxoSmithKline

Terminated

Post-marketing Surveillance Study With GSK Biologicals' Pneumococcal Vaccine in Healthy Infants in Philippines

Infections, Streptococcal

Philippines
University of Birmingham
Wellcome Trust; University Hospital Birmingham NHS Foundation Trust

Unknown

Investigating the Immune System in chrONIC Kidney Disease. (SONIC)

Immune System Diseases | Chronic Kidney Disease

United Kingdom
Novartis Vaccines

Completed

A Phase 3B, Open Label, Multi-Center Study to Evaluate the Safety, Tolerability and Immunogenicity of Novartis Meningococcal B Recombinant Vaccine When Administered Alone to Healthy Infants According to Different Immunization Schedules and to Healthy Children Aged 2 to 10 Years

Meningococcal Disease | Meningococcal Meningitis

Spain, Brazil, Hungary, Peru
Sanofi Pasteur, a Sanofi Company

Completed

A Study of 2 Doses of Menactra®, a Meningococcal Conjugate Vaccine in Healthy Toddlers

Measles | Rubella | Mumps | Varicella | Meningococcal Meningitis

United States
Sanofi Pasteur, a Sanofi Company

Completed

Immunogenicity and Safety of Pediatric Vaccines When Administered With Menactra® in Healthy Toddlers

Measles | Rubella | Mumps | Varicella | Meningococcal Meningitis

United States, Puerto Rico
Assistance Publique - Hôpitaux de Paris

Unknown

Immunogenicity of a Combined Anti-pneumococcal Vaccine Schedule in Patients With ANCA-associated Vasculitis

ANCA-associated Vasculitis | Pneumococcal Infection

France
Institut National de la Santé Et de la Recherche...

Terminated

"Prime Boost" Vaccination Strategy Combining Conjugated Anti- Pneumococcal Vaccine (s0) and Polysaccharide Anti- Pneumococcal Vaccine (s4) Compared to Polysaccharide Anti- Pneumococcal Vaccine Alone (s4) In Patients With Common Variable Immunodeficiency (EVAD)

Common Variable Immunodeficiency

France
SK Chemicals Co., Ltd.

Completed

Study Immunogenicity and Safety of 13-valent Pneumococcal Conjugate Vaccine

Pneumococcal Infections
Pfizer

Completed

Prevenar Special Use-result Surveillance in Japan (Regulatory PostMarketing Commitment Plan)

Streptococcus Pneumoniae | Pneumococcal Vaccine

Japan
Karolinska University Hospital

Completed

Pneumococcal Vaccine in Untreated CLL Patients

Chronic Lymphocytic Leukemia

Sweden
Mayo Clinic

Completed

Analysis of the Mechanisms of Protective Humoral Immunity in Response to the Pneumococcal Vaccine

Healthy

United States
Sanofi Pasteur, a Sanofi Company

Completed

Antibody Persistence at Age 3.5 and 4.5 Years After Primary and Booster DTaP-IPV-Hep B-PRP~T or Infanrix Hexa Vaccination

Hepatitis B | Whooping Cough | Tetanus | Diphtheria | Poliomyelitis | Haemophilus Influenzae Type b

Colombia, Costa Rica
Genocea Biosciences, Inc.

Completed

Safety and Immunogenicity Study of Prophylactic Streptococcus Pneumoniae Vaccine

Streptococcus Pneumoniae

United States

3

Subscribe